"Daptomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
| Descriptor ID |
D017576
|
| MeSH Number(s) |
D04.345.566.270 D10.477.500 D12.644.365.500 D12.644.641.270
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Daptomycin".
Below are MeSH descriptors whose meaning is more specific than "Daptomycin".
This graph shows the total number of publications written about "Daptomycin" by people in this website by year, and whether "Daptomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Daptomycin" by people in Profiles.
-
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. Int J Antimicrob Agents. 2020 Dec; 56(6):106210.
-
Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains. Appl Microbiol Biotechnol. 2020 Sep; 104(18):7853-7865.
-
Comparative Genome Analysis of the Daptomycin-Resistant Streptococcus anginosus Strain J4206 Associated with Breakthrough Bacteremia. Genome Biol Evol. 2016 12 31; 8(11):3446-3459.
-
Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports. Drug Saf. 2012 Jun 01; 35(6):447-57.
-
Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides. J Okla State Med Assoc. 2007 Apr; 100(4):105-11.